OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR ‐mutant non‐small cell lung cancer
Julie M. Janssen, Remy B. Verheijen, Tirsa T van Duijl, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 8, pp. 1916-1925
Open Access | Times Cited: 17
Julie M. Janssen, Remy B. Verheijen, Tirsa T van Duijl, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 8, pp. 1916-1925
Open Access | Times Cited: 17
Showing 17 citing articles:
Machine Learning in Modeling Disease Trajectory and Treatment Outcomes: An Emerging Enabler for Model‐Informed Precision Medicine
Nadia Terranova, Karthik Venkatakrishnan
Clinical Pharmacology & Therapeutics (2023) Vol. 115, Iss. 4, pp. 720-726
Open Access | Times Cited: 30
Nadia Terranova, Karthik Venkatakrishnan
Clinical Pharmacology & Therapeutics (2023) Vol. 115, Iss. 4, pp. 720-726
Open Access | Times Cited: 30
Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development
Wei Gao, Jiang Liu, Blerta Shtylla, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 13, Iss. 5, pp. 691-709
Open Access | Times Cited: 23
Wei Gao, Jiang Liu, Blerta Shtylla, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 13, Iss. 5, pp. 691-709
Open Access | Times Cited: 23
A review of mechanistic learning in mathematical oncology
John Metzcar, Catherine R. Jutzeler, Paul Macklin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
John Metzcar, Catherine R. Jutzeler, Paul Macklin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Toward Project Optimus for Oncology Precision Medicine: Multi‐Dimensional Dose Optimization Enabled by Quantitative Clinical Pharmacology
Karthik Venkatakrishnan, Piet H. van der Graaf
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 5, pp. 927-932
Open Access | Times Cited: 25
Karthik Venkatakrishnan, Piet H. van der Graaf
Clinical Pharmacology & Therapeutics (2022) Vol. 112, Iss. 5, pp. 927-932
Open Access | Times Cited: 25
Support to early clinical decisions in drug development and personalised medicine with checkpoint inhibitors using dynamic biomarker-overall survival models
René Bruno, Pascal Chanu, Matts Kågedal, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 9, pp. 1383-1388
Open Access | Times Cited: 14
René Bruno, Pascal Chanu, Matts Kågedal, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 9, pp. 1383-1388
Open Access | Times Cited: 14
Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper
Divya Samineni, Karthik Venkatakrishnan, Ahmed A. Othman, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 531-545
Open Access | Times Cited: 6
Divya Samineni, Karthik Venkatakrishnan, Ahmed A. Othman, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 531-545
Open Access | Times Cited: 6
Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib
Anyue Yin, G. Veerman, J. G. Coen van Hasselt, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 4, pp. 612-623
Open Access | Times Cited: 4
Anyue Yin, G. Veerman, J. G. Coen van Hasselt, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 4, pp. 612-623
Open Access | Times Cited: 4
Moving the needle for oncology dose optimization: A call for action
Karthik Venkatakrishnan, Priya Jayachandran, Shirley K. Seo, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 6, pp. 909-918
Open Access | Times Cited: 4
Karthik Venkatakrishnan, Priya Jayachandran, Shirley K. Seo, et al.
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 6, pp. 909-918
Open Access | Times Cited: 4
Computational Modeling for Circulating Cell-Free DNA in Clinical Oncology
Linh Nguyen Phuong, Sébastien Salas, Sébastien Benzekry
JCO Clinical Cancer Informatics (2025), Iss. 9
Open Access
Linh Nguyen Phuong, Sébastien Salas, Sébastien Benzekry
JCO Clinical Cancer Informatics (2025), Iss. 9
Open Access
Moving the Needle for Oncology Dose Optimization: A Call for Action
Karthik Venkatakrishnan, Priya Jayachandran, Shirley K. Seo, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 115, Iss. 6, pp. 1187-1197
Open Access | Times Cited: 2
Karthik Venkatakrishnan, Priya Jayachandran, Shirley K. Seo, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 115, Iss. 6, pp. 1187-1197
Open Access | Times Cited: 2
Screening approaches for lung cancer by blood-based biomarkers: Challenges and opportunities
Daan van den Broek, Harry J.M. Groen
Tumor Biology (2023) Vol. 46, Iss. s1, pp. S65-S80
Open Access | Times Cited: 2
Daan van den Broek, Harry J.M. Groen
Tumor Biology (2023) Vol. 46, Iss. s1, pp. S65-S80
Open Access | Times Cited: 2
Longitudinal Assessment of Circulating Tumor DNA: A Proposed Statistical Framework
Christopher R. Pretz, Jiemin Liao, Caroline Weipert, et al.
Research Square (Research Square) (2024)
Open Access
Christopher R. Pretz, Jiemin Liao, Caroline Weipert, et al.
Research Square (Research Square) (2024)
Open Access
Moving the needle for oncology dose optimization: A call for action
Karthik Venkatakrishnan, Priya Jayachandran, Shirley K. Seo, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 6
Open Access
Karthik Venkatakrishnan, Priya Jayachandran, Shirley K. Seo, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 6
Open Access
Model‐informed Evidence for Clinical Non‐inferiority of Every‐2‐Weeks Versus Standard Weekly Dosing Schedule of Cetuximab in Metastatic Colorectal Cancer
Ana‐Marija Milenković‐Grišić, Siobhán Hayes, Colm Farrell, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 4, pp. 1071-1081
Open Access
Ana‐Marija Milenković‐Grišić, Siobhán Hayes, Colm Farrell, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 4, pp. 1071-1081
Open Access
The Potential of Disease Progression Modeling to Advance Clinical Development and Decision Making
Summer Starling, Lindsay Kehoe, Bruce K. Burnett, et al.
Clinical Pharmacology & Therapeutics (2024)
Open Access
Summer Starling, Lindsay Kehoe, Bruce K. Burnett, et al.
Clinical Pharmacology & Therapeutics (2024)
Open Access
Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
Han Liu, Eman Ibrahim, Maddalena Centanni, et al.
Advanced Drug Delivery Reviews (2024), pp. 115476-115476
Open Access
Han Liu, Eman Ibrahim, Maddalena Centanni, et al.
Advanced Drug Delivery Reviews (2024), pp. 115476-115476
Open Access
